SURF - Surface Oncology EPS misses by $0.04 beats on revenue November, 04 2021 08:16 AM Surface Oncology Inc. Surface Oncology (NASDAQ:SURF): Q3 GAAP EPS of -$0.44 misses by $0.04. Revenue of $392M beats by $389.54M. Press Release For further details see: Surface Oncology EPS misses by $0.04, beats on revenue